Entera Bio
ENTX
3 hedge funds and large institutions have $4.57M invested in Entera Bio in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
6.1% more ownership
Funds ownership: 0% → 6.1% (+6.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$2.99M |
| 2 |
DAM
DLD Asset Management
New York
|
+$1.56M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$9.05K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KCM
1
Knoll Capital Management
Miami,
Florida
| $3M | +$2.99M | +475,540 | New |
|
|
DAM
2
DLD Asset Management
New York
| $1.57M | +$1.56M | +248,500 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $9K | +$9.05K | +1,439 | New |
|
ENTX Hedge Fund Activity: Q2 2018 in Review
3 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q2 2018, worth a combined $4.57M.
Buyers outnumbered sellers: 3 funds opened new ENTX positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Knoll Capital Management, opening a new position worth an estimated $2.99M.
- 3 institutional investors held Entera Bio (ENTX) as of Q2 2018, up from 0 in Q1 2018.
- Funds reported $4.57M of Entera Bio stock for Q2 2018.
- 3 funds opened new Entera Bio positions in Q2 2018 and 0 closed out, a net change of +3 holders.
- The largest Entera Bio buyer in Q2 2018 was Knoll Capital Management, an estimated $2.99M added.
Based on aggregated 13F filings for Q2 2018.